Association between baseline haemoglobin levels and radiographic joint damage progression in patients with rheumatoid arthritis treated with baricitinib or standard of care by Moeller, B, Durez, P, Finckh, A, Lopez-Romero, P, Perrier, C, de Leonardis, F, De La Torre, I, Taylor, P

Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM by Fautrel, B, Kirkham, B, Pope, J, Takeuchi, T, Gaich, C, Quebe, A, Zhu, B, De La Torre, I, De Leonardis, F, Taylor, P

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis by Van De Laar CJ, Oude Voshaar MAH, Fakhouri WKH, Zaremba-Pechmann L, De Leonardis F, De La Torre I, Van De Laar MAFJ

Get full text

Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA by Van De Laar, M, Pope, J, Lee, Y, Fautrel, B, Ikeda, K, Quebe, A, Zhang, X, Gaich, C, De Leonardis, F, Lisse, J, Workman, J, Taylor, P

Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patient... by Fautrel, B, Zhu, B, Taylor, P, van de Laar, M, Emery, P, De Leonardis, F, Gaich, C, Nicolay, C, Kadziola, Z, De La Torre, I, Fleischmann, R

Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in rheumatoid arthritis patient... by Fautrel, B, Zhu, B, Taylor, PC, van de Laar, M, Emery, P, De Leonardis, F, Kannowski, CL, Nicolay, C, Kadziola, Z, De La Torre, I, Fleischmann, R

Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors by Taylor, P, Fleischmann, R, Takeuchi, T, Pope, J, Genovese, M, Zhu, B, Gaich, C, Zhang, X, Dickson, C, Quebe, A, De Leonardis, F, Cardoso, A, Kouris, I, Durez, P

Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis by Emery, P, Dudler, J, Smolen, J, Zerbini, C, Burmester, G, Fautrel, B, Van Der Laar, M, Fleischmann, R, Fakhouri, W, De Leonardis, F, Zhu, B, Kadziola, Z, De La Torre, I, Perrier, C, Taylor, P